Charles River Laboratories CRL Noncontrolling interests in subsidiaries
Noncontrolling interests in subsidiaries at other companies
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept us-gaap:MinorityInterest.
The official record: Charles River Laboratories’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Charles River Laboratories's noncontrolling interests in subsidiaries.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Charles River Laboratories's noncontrolling interests in subsidiaries?
- Charles River Laboratories (CRL) reported noncontrolling interests in subsidiaries of $5.82M in Q1 2026.
- How has Charles River Laboratories's noncontrolling interests in subsidiaries changed year-over-year?
- Charles River Laboratories's noncontrolling interests in subsidiaries increased by 0.6% year-over-year, from $5.78M to $5.82M.
- What is the long-term trend for Charles River Laboratories's noncontrolling interests in subsidiaries?
- Over 5 years (2020 to 2025), Charles River Laboratories's noncontrolling interests in subsidiaries has grown at a 8.2% compound annual growth rate (CAGR), from $3.57M to $5.3M.
- What does noncontrolling interests in subsidiaries mean?
- This represents the portion of a subsidiary's net assets that is owned by outside shareholders rather than the parent company. It is reported within equity to show the total value of the subsidiary's assets and liabilities that are not attributable to the parent. It reflects the non-controlling stake in consolidated entities.